Eric Mandelblatt’s Lam Research LRCX Stock Holding History

Eric Mandelblatt’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,657,590	Closed	-$125M	–	25
2019 Q2	$125M	Buy	6,657,590 +787,260	+13%	+$14.9M	1.88%	17
2019 Q1	$105M	Buy	+5,870,330	New	+$97.9M	1.9%	16

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eric Mandelblatt's LRCX Position: Q3 2019 in Review

Eric Mandelblatt sold out of Lam Research (LRCX) in Q3 2019, closing a stake of 6,657,590 shares — an estimated $125M sold.

Eric Mandelblatt first reported a position in LRCX in Q1 2019 and held it in 2 quarters. The position peaked at $125M in Q2 2019. 882 funds tracked by Wall St. Rank hold LRCX as of Q3 2019.

Eric Mandelblatt reported no remaining Lam Research position as of Q3 2019 after selling out during the quarter.
Eric Mandelblatt sold 6,657,590 Lam Research shares in Q3 2019, an estimated $125M.
Eric Mandelblatt first reported a position in Lam Research in Q1 2019 and held it in 2 quarters.
Eric Mandelblatt's Lam Research position peaked at $125M in Q2 2019.
882 funds tracked by Wall St. Rank held Lam Research as of Q3 2019.

Based on Soroban Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.